Displaying 1–25 of 58 results for MasterControl
“Seeing something and saying something” can be applied to the life sciences when a lack of transparency could result in a company facing stiff regulatory action.
Pharma Manufacturing's annual Pharma Innovation Award winners offer slices of innovation
How innovative EBR solutions are making it easier to scrap paper-based processes
Using the data deluge for better decision-making on the plant floor
Tech Talk: Business Management Solutions
To ensure that a supplier can provide the material or products meeting quality specifications and requirements, consider these five things when conducting an onsite supplier audit
Would zombies be more successful at world domination if they used an electronic quality management system?
In the framework of QbD, how is quality defined?
I work for a pharma company that wants to expand its product portfolio with combination products. I�
By integrating data systems and processes, companies can reduce errors and human touch all the way through a product’s lifecycle
How can we leverage our existing ERP if we adopt an electronic QMS? What are the things we should lo
By implementing supplier audits collaboratively and applying robust quality management tools, manufacturers are much more likely to achieve supplier quality success
What is the best way to write an SOP?
What type of educational background and characteristics do I need to succeed in the quality field?
Adopting Enterprise Quality Management Software is an imperative Pharma companies can’t ignore
Explore MasterControls’s quality, compliance and risk management solutions addressing these challenges.
Our company fears that evolving beyond our paper-based record keeping systems will lead to large exp
PhMs virtual panel weighs in on information technology trends in pharmaceutical manufacturing
The Pharmaceutical Industry's Transition to Electronic Processes
How Effective Document Management Helps Pharmaceutical Companies Accelerate Time to Market
Six Corporate Oversights of Quality and Compliance Issues in Pharmaceutical Environments
In the drug development process, time is indeed money. On the one hand, it takes a decade or longer to develop a new medicine. On the other hand, the patent for a new drug typically lasts 20 years. That leaves a manufacturer only a few years of market exclusivity before its patent expires and ...
The CAPA is still necessary, but it needs to morph into something new under the QbD and PAT manufacturing examples, argues Contributing Editor Emil Ciurczak.
Manhattan in the spring, a bustling show floor and thought-provoking educational sessions provide all the reason anyone should need to attend this years event